A COVID-19 vaccine is likely to become available by early 2021.

Russia approved its vaccine, but WHO is yet to give it clearance. There is no confirmation on the availability of any COVID-19 vaccine by early 2021.

Russia approved its vaccine, but WHO is yet to give it clearance. There is no confirmation on the availability of any COVID-19 vaccine by early 2021.Indian pharmaceutical company Zydus Cadila announced that its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D, was found to be safe and well-tolerated in phase 1 clinical trial. The independent Data Safety Monitoring Board (DSMB) endorsed the seven-day safety of the vaccine. The company scheduled phase 2 clinical trials on August 6, 2020.

According to the World Health Organization, 26 experimental vaccines against the disease are under clinical evaluation, with six candidates moving into the final phase of testing. The DNA vaccine of Zydus Cadila has completed Phase 1 and will begin the Phase 2 trial. As of now, there is no specific antiviral drug or vaccine available yet for COVID-19.

The Russian Health Ministry has approved a vaccine as safe for distribution after only passing the phase 1 trials. The WHO has not recognized it as safe as of yet.

The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.